Real-world evidence of the use of glucocorticoids for severe COVID-19.

Alejandra Albarrán-SánchezClaudia Ramírez-RenteríaMoisés MercadoMiriam Sánchez-GarcíaCorazón de Jesús Barrientos-FloresAldo Ferreira-Hermosillo

Published in: Therapeutic advances in endocrinology and metabolism (2022)

The use of steroids in severe COVID-19 reduces mortality only at the dose proposed in the RECOVERY study in the younger population. No benefit of the use of steroids was observed in patients with older age or higher number of comorbidities.

Keyphrases

coronavirus disease
sars cov
early onset
cardiovascular events
respiratory syndrome coronavirus
risk factors
cardiovascular disease
community dwelling